Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Palmer

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 11, 2013
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errorsThomas J Pugh, Richard A Amos, Sandra John Baptiste, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomesSarah McAvoy, Katherine Ciura, Caimiao Wei, et al.
International Journal of Particle Therapy|July 21, 2021
Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to DateDanmeng Huang, Steven J Frank, Vivek Verma, et al.
Kidney International|March 27, 2019
Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutationYoshiyasu Ueda, Takashi Miwa, Daisuke Ito, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancerSarah A McAvoy, Katherine T Ciura, Justin M Rineer, et al.
Nature Communications|July 13, 2022
Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regenerationMichael S Balzer, Tomohito Doke, Ya-Wen Yang, et al.
Journal of Applied Clinical Medical Physics|December 24, 2018
Characterization of a new physical phantom for testing rigid and deformable image registrationRichard Y Wu, Amy Y Liu, Paul Wisdom, et al.
Archives of Pathology & Laboratory Medicine|February 20, 2018
Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring SystemJarcy Zee, Jeffrey B Hodgin, Laura H Mariani, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2010
Esophageal cancer dose escalation using a simultaneous integrated boost techniqueJames Welsh, Matthew B Palmer, Jaffer A Ajani, et al.
Medical Physics|July 3, 2016
Quantitative analysis of treatment process time and throughput capacity for spot scanning proton therapyKazumichi Suzuki, Matthew B Palmer, Narayan Sahoo, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 11, 2013
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errorsThomas J Pugh, Richard A Amos, Sandra John Baptiste, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomesSarah McAvoy, Katherine Ciura, Caimiao Wei, et al.
International Journal of Particle Therapy|July 21, 2021
Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to DateDanmeng Huang, Steven J Frank, Vivek Verma, et al.
Kidney International|March 27, 2019
Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutationYoshiyasu Ueda, Takashi Miwa, Daisuke Ito, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancerSarah A McAvoy, Katherine T Ciura, Justin M Rineer, et al.
Nature Communications|July 13, 2022
Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regenerationMichael S Balzer, Tomohito Doke, Ya-Wen Yang, et al.
Journal of Applied Clinical Medical Physics|December 24, 2018
Characterization of a new physical phantom for testing rigid and deformable image registrationRichard Y Wu, Amy Y Liu, Paul Wisdom, et al.
Archives of Pathology & Laboratory Medicine|February 20, 2018
Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring SystemJarcy Zee, Jeffrey B Hodgin, Laura H Mariani, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2010
Esophageal cancer dose escalation using a simultaneous integrated boost techniqueJames Welsh, Matthew B Palmer, Jaffer A Ajani, et al.
Medical Physics|July 3, 2016
Quantitative analysis of treatment process time and throughput capacity for spot scanning proton therapyKazumichi Suzuki, Matthew B Palmer, Narayan Sahoo, et al.
Pageof 6